Loading
HKSEHealthcareMedical - Devices
Latest quote
HK$6.70
−HK$0.10 · -1.47%
MicroTech Medical (Hangzhou) Co., Ltd. focuses on the innovation, production, and market distribution of essential medical devices and consumables for diabetes management. Its operations extend across the People's Republic of China and into global markets. The company offers a comprehensive range of products, including the Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, traditional blood glucose monitoring systems, and advanced closed-loop artificial pancreas technology. Beyond its core offerings, MicroTech Medical is also actively involved in engineering and technological research, experimentation, and developmental endeavors. The firm, established in 2011, maintains its headquarters in Hangzhou, People's Republic of China.
Latest quote
HK$6.70
−HK$0.10 · -1.47%
Regular session · HKT · Market data may be delayed.
MicroTech Medical (Hangzhou) Co., Ltd. focuses on the innovation, production, and market distribution of essential medical devices and consumables for diabetes management. Its operations extend across the People's Republic of China and into global markets. The company offers a comprehensive range of products, including the Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, traditional blood glucose monitoring systems, and advanced closed-loop artificial pancreas technology. Beyond its core offerings, MicroTech Medical is also actively involved in engineering and technological research, experimentation, and developmental endeavors. The firm, established in 2011, maintains its headquarters in Hangzhou, People's Republic of China.
Day range
Current HK$6.70
52-week range
Current HK$6.70
Regular session · HKT · Market data may be delayed.
MicroTech Medical (Hangzhou) Co., Ltd. focuses on the innovation, production, and market distribution of essential medical devices and consumables for diabetes management. Its operations extend across the People's Republic of China and into global markets. The company offers a comprehensive range of products, including the Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, traditional blood glucose monitoring systems, and advanced closed-loop artificial pancreas technology. Beyond its core offerings, MicroTech Medical is also actively involved in engineering and technological research, experimentation, and developmental endeavors. The firm, established in 2011, maintains its headquarters in Hangzhou, People's Republic of China.
Day range
Current HK$6.70
52-week range
Current HK$6.70
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 660.79M CNY | 345.62M CNY | 248.35M CNY | 173.54M CNY | 151.4M CNY |
| Cost of goods sold | 303.36M CNY | 162.77M CNY | 125.13M CNY | 93.89M CNY | 80.52M CNY |
| Gross profit | 357.42M CNY | 182.85M CNY | 123.22M CNY | 79.66M CNY | 70.88M CNY |
| Research and development | 76.34M CNY | 76.56M CNY | 70.1M CNY | 30.6M CNY | 14.82M CNY |
| Selling, general, and administrative | 170.02M CNY | 151.73M CNY | 161.52M CNY | 158.99M CNY | 94.27M CNY |
| Operating expenses | 313.45M CNY | 242.6M CNY | 243.49M CNY | 197.89M CNY | 131.05M CNY |
| Interest income | 46.54M CNY | 62.84M CNY | 68.24M CNY | 55.72M CNY | 23.32M CNY |
| Interest expense | 446.05K CNY | 676.45K CNY | 313.19K CNY | 147K CNY | 17K CNY |
| Depreciation and amortization | 11.2M CNY | 10.37M CNY | 11.17M CNY | 10.15M CNY | 8.33M CNY |
| Operating income | 43.97M CNY | −62.46M CNY | −120.27M CNY | −32.19M CNY | −60.17M CNY |
| Net income | 40.15M CNY | −63.12M CNY | −125.02M CNY | −35.04M CNY | −48.18M CNY |
Company facts updated Sep 7, 2026.
Recent quarterly results
Recent quarterly results
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
